ATM Serine/Threonine Kinase

Key regulator of DNA damage response and genomic stability

Gene Information Card

Symbol ATM
Full Name ATM serine/threonine kinase
Gene Type Protein coding
Chromosomal Location 11q22.3
NCBI Gene ID 472 ncbi.nlm.nih.gov/gene/472
Ensembl ID ENSG00000149311
UniProt ID Q13315
OMIM ID 607585
HGNC ID 795
Aliases ATA, ATC, ATD, ATE, ATDC, TEL1, TELO1

Description

The ATM gene encodes a serine/threonine protein kinase that is a master regulator of the DNA damage response, particularly for double-strand breaks. It activates cell cycle checkpoints, DNA repair, and apoptosis. Mutations in ATM cause ataxia telangiectasia and increase cancer risk.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Ataxia telangiectasia Loss-of-function mutations impair DNA repair, leading to neurodegeneration, immunodeficiency, and cancer predisposition OMIM #208900
Breast cancer ATM heterozygous mutations increase risk; defective DNA damage response promotes genomic instability ClinVar, COSMIC
T-cell prolymphocytic leukemia ATM biallelic inactivation common; loss of checkpoint control drives proliferation COSMIC, OMIM #609190

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 12.3 Medium
Brain (cerebellum) 8.5 Medium
Lymph node 6.2 Low
Breast 4.1 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa 10.5 Cervical cancer line
MCF7 7.8 Breast cancer line
K562 9.2 Leukemia line
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.7271T>G (p.Val2424Gly) Missense Rare Dominant-negative effect; increases breast cancer risk
c.7630_7631del (p.Arg2544fs) Frameshift Common in ataxia telangiectasia Loss of function; truncation
c.9022C>T (p.Arg3008Cys) Missense Rare Impaired kinase activity; cancer susceptibility
Mutation functional classification

Loss of Function (LOF)

Most ATM mutations are loss-of-function, leading to defective DNA repair, genomic instability, and predisposition to ataxia telangiectasia and cancers.

Gain of Function (GOF)

Rare; some missense variants may confer altered kinase activity but not clearly gain-of-function.

Dominant Negative (DN)

Certain missense mutations (e.g., p.Val2424Gly) act as dominant-negative, interfering with wild-type ATM function and increasing cancer risk.

Gene Ontology (GO)

• DNA damage response • double-strand break repair
• protein kinase activity • cell cycle checkpoint
• apoptosis

Pathways

ATM signaling in DNA damage response
p53 pathway
BRCA1-dependent DNA repair

Protein Summary

ATM is a large serine/threonine kinase (350 kDa) that phosphorylates key substrates such as p53, BRCA1, and CHK2 to coordinate DNA repair, cell cycle arrest, and apoptosis. It is activated by DNA double-strand breaks and localizes to damage sites via the MRN complex.

Related Products

Product name Cat.No. Species Gene ID
ATM Knockout HEK293T Cell Line EDJ-KQ211 Human 472 Details Get a Quote
GATM Knockout HEK293 Cell Line EDJ-KQ4684 Human 2628 Details Get a Quote
ATMIN Knockout HEK293 Cell Line EDJ-KQ7948 Human 23300 Details Get a Quote
ATM Knockout HEK293 Cell Line EDJ-KQ17856 Human 472 Details Get a Quote
ATM Knockout A-549 Cell Line EDJ-KQ18114 Human 472 Details Get a Quote
GATM Knockout A-549 Cell Line EDJ-KQ26145 Human 2628 Details Get a Quote
ATM Knockout HCT 116 Cell Line EDC90546 Human 472 Details Get a Quote
ATM Knockout HeLa Cell Line EDJ-KQ18912 Human 472 Details Get a Quote
GATM Knockout HCT 116 Cell Line EDJ-KQ27388 Human 2628 Details Get a Quote
GATM Knockout HeLa Cell Line EDJ-KQ27389 Human 2628 Details Get a Quote
ATMIN Knockout A-549 Cell Line EDJ-KQ33614 Human 23300 Details Get a Quote
ATMIN Knockout HCT 116 Cell Line EDJ-KQ33615 Human 23300 Details Get a Quote
ATMIN Knockout HeLa Cell Line EDJ-KQ33616 Human 23300 Details Get a Quote
ATM Knockout 22Rv1 Cell Line EDJ-KZ104 Human 472 Details Get a Quote
Displaying Records 1 To 14 Of 14 Records
Contact Us
*
*
*
*
How did you hear about us: